Kura Oncology Inc share price logo

Kura Oncology Inc Share Price

NASDAQ: KURA

Small Cap

$8.26

-0.17

(-2.02%)

as on

Kura Oncology Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $8.17
    $8.60
    downward going graph

    1.09%

    Downside

    4.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.41
    $12.49
    downward going graph

    34.50%

    Downside

    51.21%

    Upside

    downward going graph

Kura Oncology Inc share price movements today

Previous Close
$8.43
Open
$8.43
Volume
1.2M
Day's Low - High
$8.17 - $8.60
52 Week Low - High
$5.41 - $12.49

Kura Oncology Inc Historical Returns

1 Month Return
-2.36 %
3 Month Return
-16.06 %
1 Year Return
+ 5.36 %
3 Year Return
-33.06 %
5 Year Return
-69.33 %

Kura Oncology Inc Stock Fundamentals & Key Indicators

Check Kura Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$744.6M

EPS (TTM)

-3.2733

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-302.6M

Revenue (TTM)

67.5M

Profit Margin

0.00%

Return On Equity TTM

-94.82%

Kura Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kura Oncology Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Kura Oncology Inc image
Kura Oncology Inc
BUY$744.6M-69.33%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Kura Oncology Inc Stock including INR - Dollar returns

The Kura Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kura Oncology Inc investment value today

Current value as on today

₹1,14,802

Returns

₹14,802

(+14.8%)

Returns from Kura Oncology Inc Stock

₹5,357 (+5.36%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Kura Oncology Inc Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Kura Oncology Inc. Average target price of $32.27

Kura Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Kura Oncology Inc.

What analysts predicted

74.4%UPSIDE

Target Price

$32.27

Current Price

$8.26

Analyzed by

20 Analysts

Target

$32.27

Kura Oncology Inc target price $32.27, a slight upside of 74.4% compared to current price of $8.26. According to 20 analysts rating.

Kura Oncology Inc Stock’s Investor Sentiment and Interest

Search interest for Kura Oncology Inc Stock has increased by 61% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:61% versus previous 30 day period

Kura Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
1
-
-
-
53
14
15
20
17
Gross Profit
0
0
0
0
0
53
14
15
17
16
Operating Income
-42
-46
-54
-56
-59
-22
-64
-72
-79
-86
EBITDA
-37
-42
-48
-50
-53
-16
-64
-65
-73
-85
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-38
-42
-49
-50
-54
-17
-57
-66
-74
-80
Income Tax Expense
0
2
0
-
-
2
0
-
-
0
Net Income
-38
-42
-49
-50
-54
-19
-57
-66
-74
-80
Net Profit Margin
0.00%
-3368.98%
0.00%
0.00%
0.00%
-35.66%
-407.07%
-432.51%
-357.19%
-467.23%

Kura Oncology Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
53
67
Gross Profit
0
0
0
-
0
0
0
0
53
67
Operating Income
-28
-36
-62
-67
-91
-131
-139
-165
-193
-303
EBITDA
-28
-36
-62
-67
-88
-129
-134
-150
-169
-303
Interest Expense
0
0
0
0
0
0
0
1
1
1
Depreciation
-
0
0
0
0
0
0
0
0
1
Income Before Tax
-27
-35
-60
-63
-89
-130
-135
-152
-171
-278
Income Tax Expense
0
0
3
-4
0
0
0
-
2
0
Net Income
-27
-35
-60
-63
-89
-130
-135
-152
-173
-278
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-322.89%
-412.95%

Kura Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-42
-49
-50
-54
-19
-57
-66
-74
-80
Operating Cash Flow
-34
-48
-42
-43
269
-71
-28
-80
117
Investing Cash Flow
42
-95
43
45
-94
-101
58
93
-64
Financing Cash Flow
0
148
3
2
0
0
0
-
1
Change in Cash
8
4
3
4
174
-173
30
13
53

Kura Oncology Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-35
-60
-63
-89
-130
-135
-152
-173
-278
Operating Cash Flow
-28
-48
-54
-69
-104
-110
-124
134
-64
Investing Cash Flow
-23
-79
-46
-99
-126
32
15
-101
-13
Financing Cash Flow
53
132
111
469
-3
38
94
154
1
Change in Cash
1
4
10
299
-234
-38
-14
187
-75

Global Institutional Holdings in Kura Oncology Inc

Funds
Holdings
State Street Corp
3.78%
Millennium Management LLC
2.37%
AQR Capital Management LLC
3.47%
Goldman Sachs Group Inc
1.08%
Qube Research & Technologies
1.94%
See all

Insights on Kura Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Kura Oncology Inc has experienced a drawdown of -31.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 28.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 5.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, KURA stock has moved down by -26.7%

About Kura Oncology Inc

at kura oncology, we are committed to realizing the promise of precision medicines for cancer. the genomics revolution is transforming how we treat cancer. we now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. this new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. we are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. our development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias. our goal is to help patients with cancer lead better, longer lives.
OrganisationKura Oncology Inc
Headquarters4930 Directors Place, San Diego, CA, United States, 92121
IndustryHealth Technology
CEODr. Troy Edward Wilson J.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Kura Oncology Inc

Name

Title

Dr. Troy Edward Wilson J.D., Ph.D.

Chairman, CEO & President

Mr. Thomas Doyle

Senior Vice President of Finance & Accounting

Dr. Mollie Leoni M.D.

Chief Medical Officer

Mr. Brian T. Powl M.B.A., M.S.

Chief Commercial Officer

Ms. Kathleen Ford

Chief Operating Officer

Ms. Teresa Brophy Bair Esq., J.D.

Chief Legal Officer & Corporate Secretary

Dr. Francis J. Burrows Ph.D.

Chief Scientific Officer

Mr. Greg Mann

Senior Vice President of Investor Relations & Corporate Affairs

Dr. Roger Bakale Ph.D.

Senior Vice President of Manufacturing & Supply Chain

Mr. Samir Vattompadam M.S.

Senior Vice President of Global Program Leadership

FAQs

What is Kura Oncology Inc share price today?

Kura Oncology Inc share price today is $8.26 as on at the close of the market. Kura Oncology Inc share today touched a day high of $8.6 and a low of $8.17.

What is the 52 week high and 52 week low for Kura Oncology Inc share?

Kura Oncology Inc share touched a 52 week high of $12.49 on and a 52 week low of $5.41 on . Kura Oncology Inc stock price today i.e. is closed at $8.26,which is 33.87% down from its 52 week high and 52.68% up from its 52 week low.

What is Kura Oncology Inc's market capitalisation today?

Kura Oncology Inc market capitalisation is $0.00T as on .

How to invest in Kura Oncology Inc Stock (KURA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kura Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kura Oncology Inc Shares that will get you 0.1816 shares as per Kura Oncology Inc share price of $8.26 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Kura Oncology Inc Stock (KURA) from India?

Indian investors can start investing in Kura Oncology Inc (KURA) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Kura Oncology Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Kura Oncology Inc share’s latest price of $8.26 as on March 21, 2026 at 1:29 am IST, you will get 1.2107 shares of Kura Oncology Inc. Learn more about fractional shares .

What are the returns that Kura Oncology Inc has given to Indian investors in the last 5 years?

Kura Oncology Inc stock has given -69.33% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?